Filing Flows › Marimed (MRMD) › Q1 2025
Marimed (MRMD) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 8, 2025
Marimed (MRMD) reported revenue of $37.9M for the first quarter 2025 (Q1 2025), -0.1% from a year earlier and -3% from the quarter before. Operating margin was -2.2%, net loss $5.5M (14.5% of revenue).
Marimed, Q1 2025: revenue $37.9M (-0.1% year over year), operating margin -2.2%, net loss $5.5M, operating cash flow $1.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $37.9M | -3% | -0.1% |
| Operating profit | −$851K | — | — |
| Net earnings | −$5.5M | — | — |
| Operating cash flow | $1.3M | — | -60% |
| Free cash flow | $1.0M | — | — |
What changed
Revenue was $37.9M in Q1 2025, roughly flat year over year and down 3% from the previous quarter. Product sales - retail was the largest line at 55% of revenue. Product sales - retail lost $1.6M year over year (down 7%), 5804% of the total change.
Gross margin was 39.8%, down 3.6 points from a year earlier. Operating costs exceeded revenue by $851K, an operating margin of -2.2%. Operating expenses grew 10% against flat revenue. The fastest-growing cost line was Other operating costs (+34%). The quarter ended with a net loss of $5.5M, narrower than the previous quarter's $8.5M loss.
Operating cash flow was $1.3M (down 60% year over year). Non-cash charges added back $1.8M of depreciation and amortization and $547K of share-based compensation. Working capital and other items added $4.4M. Capital expenditures of $266K left free cash flow of $1.0M.
Questions
What was Marimed's revenue in the first quarter 2025?
Marimed (MRMD) reported revenue of $37.9M for the first quarter 2025 (Q1 2025), -0.1% from a year earlier and -3% from the quarter before.
Was Marimed profitable in the first quarter 2025?
Operating loss was $851K (-2.2% of revenue) and net loss $5.5M.
Source: Marimed 10-Q on SEC EDGAR.